K.W. Bock
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 4
-
- Glycosylation and Glycoproteins Research 2
- Wnt/β-catenin signaling in development and cancer 1
- Co-authors
- Thomas R. Tephly (1 shared paper)Daniel W. Nebert (1 shared paper)Brian Burchell (1 shared paper)Takashi Iyanagi (1 shared paper)Harry Schachter (1 shared paper)Joseph K. Ritter (1 shared paper)Keith F. Tipton (1 shared paper)Doron Lancet (1 shared paper)
- Journals
- Toxicology Letters (2 papers)Carcinogenesis (2 papers)Molecular Carcinogenesis (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
K.W. Bock
13 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Pharmacology 466
- Cancer Research 173
- Pediatrics, Perinatology and Child Health 216
- Health, Toxicology and Mutagenesis 149
- Oncology 285
Countries citing papers authored by K.W. Bock
This map shows the geographic impact of K.W. Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.W. Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.W. Bock more than expected).
Fields of papers citing papers by K.W. Bock
This network shows the impact of papers produced by K.W. Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.W. Bock. The network helps show where K.W. Bock may publish in the future.
Co-authors
The 25 scholars most cited alongside K.W. Bock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence Hit paper breakdown → | 1997 | 985 |
| 2 | 2000 | 52 | |
| 3 | 1995 | 49 | |
| 4 | 1995 | 36 | |
| 5 | 1991 | 33 | |
| 6 | 1993 | 33 | |
| 7 | 1996 | 30 | |
| 8 | 1974 | 25 | |
| 9 | 2002 | 20 | |
| 10 | 1995 | 18 | |
| 11 | 1989 | 6 | |
| 12 | 1990 | 6 | |
| 13 | 1974 | 2 |
About K.W. Bock
K.W. Bock is a scholar working on Oncology, Molecular Biology, Pharmacology, Cancer Research and Surgery, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Toxic Organic Pollutants Impact (2 papers), Glycosylation and Glycoproteins Research (2 papers), Pancreatic function and diabetes (1 paper), Environmental Toxicology and Ecotoxicology (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Pharmacology (466 citations), Cancer Research (173 citations), Pediatrics, Perinatology and Child Health (216 citations), Health, Toxicology and Mutagenesis (149 citations) and Oncology (285 citations). K.W. Bock has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Thomas R. Tephly, Daniel W. Nebert, Brian Burchell, Takashi Iyanagi, Harry Schachter, Joseph K. Ritter, Keith F. Tipton, Doron Lancet, Alain Bélanger and Jayanta Roy Chowdhury. Their work appears in journals such as Toxicology Letters, Carcinogenesis, Molecular Carcinogenesis, Naunyn-Schmiedeberg s Archives of Pharmacology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.